Exports of Romanian pharmaceuticals to reach EUR 130 mln this year

Newsroom 03/11/2011 | 14:14

The Romanian Association of Generic Pharmaceuticals Producers (APMG) warns that the volume of pharmaceuticals made in Romania and sold on the local market has decreased from 62 percent in 2006 to 41 percent in 2010. The drop in value registered in the same time frame was of 10 percent up to 14 percent.

In the last five years, local pharmaceutical producers have eliminated 1500 products for treatment schemes and there is a major risk that another 200 pharmaceutical products will also disappear from the market. APMG representatives say this is a result of pricing policy, due payments on pharmaceuticals that have expenditure accounts and through the implementation of the new claw-back tax, which lead to a 15 percent drop in volume for pharmaceuticals that were produced and sold in Romania between 2009 and 2010.

The president of APMG, Dragos Damian, states that this industry is over regulated and that imports are promoted. Romania currently houses 30 factories that produce 300 units of generic pharmaceuticals every year. Meanwhile, the rate of imports has increased to 86 percent in the last five years.

The association also stated that Romanian pharmaceuticals products are exported in 90 countries, reaching EUR 130 million in value. The Romanian pharmaceutical producers contribute with 1.5 percent to the national GDP.  

APMG members warn that unless authorities align reform measures with adequate pricing and fiscal policies, the Romanian producers will focus solely on export markets.

Ovidiu Posirca

BR Magazine | Latest Issue

Download PDF: Business Review Magazine March (II) 2024 Issue

The March (II) 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “BAT DBS Romania Hub: A Vibrant New Office For An Employee-Centric
Newsroom | 27/03/2024 | 17:32
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue